Indeed up-regulation of GCNT1 has been reported in many cancer types, including endometrial carcinoma (41), breast cancer (42), bladder cancer (43), testicular germ cell tumor (44), and colorectal and pulmonary carcinoma (45, 46). This evidence concerns the gene GCNT1 and breast carcinoma.